Charles River Laboratories | CRL - Betriebsaufwand

Aktienkurs
149.93
Täglich Wechseln
-0.92 -0.61%
Monatlich
-19.19%
Jährlich
6.05%
Q2 Prognose
147.82




Betriebsaufwand Veränderung Datum
Agilent USD 1.44B 27M 2025-12
Align Technology USD 862.03M 39.18M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cigna USD 42.21B 497.12M 2026-03
Concord Medical Services Hldg CNY 345.26M 153.27M 2025-06
CVS Health USD 95.75B 7.84B 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Elevance Health USD 43.9B 5.26B 2026-03
Humana USD 37.89B 4.57B 2026-03
Illumina USD 852M 51M 2026-03
Incyte USD 5.62B 4.5B 2026-03
Intrexon USD 61.56M 26.1M 2024-06
IQVIA Holdings USD 6.22B 4.53B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Lonza CHF 2.9B 184M 2025-06
McKesson USD 94.46B 10.04B 2026-03
Merck EUR 4.09B 687M 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Novartis USD 9.29B 507M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Quest Diagnostics USD 2.5B 76M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
United Therapeutics USD 5.9B 5.1B 2026-03
UnitedHealth USD 102.68B 7.27B 2026-03
Veradigm USD 188M 61.08M 2022-12
Waters USD 1.12B 457.15M 2026-03
West Pharmaceutical Services USD 2.99B 2.35B 2026-03